Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hauser

Showing results (131-140 of 266) with videos related to

Pageof 27
Sort By:
Parkinson'S Disease|June 17, 2022
Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational SearchGareth Morinan, Robert A Hauser, Anette Schrag, et al.
The Lancet. Neurology|February 15, 2011
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trialRobert A Hauser, Marc Cantillon, Emmanuelle Pourcher, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 28, 2006
Use of nutritional supplements in Parkinson's disease patientsSummer C Wolfrath, Amy R Borenstein, Skai Schwartz, et al.
The International Journal of Neuroscience|December 7, 2016
Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's diseaseElise G Valdés, Melissa L O'Connor, Ergun Y Uc, et al.
Journal of Parkinson'S Disease|March 27, 2023
Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary?Robert A Hauser, William G Ondo, Yi Zhang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2005
Chorea in a patient with cerebral palsy: treatment with levetiracetamMaria V Recio, Robert A Hauser, Elan D Louis, et al.
Frontiers in Neurology|October 26, 2020
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical StudiesAlberto Esquenazi, Mauricio R Delgado, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Substantial improvement in a Meige's syndrome patient with levetiracetam treatmentTheresa A Zesiewicz, Elan D Louis, Kelly L Sullivan, et al.
Clinical Rheumatology|October 17, 2007
Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1Theresa A Zesiewicz, W Reed Shimberg, Robert A Hauser, et al.
Neurology and Therapy|February 2, 2022
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentRobert A Hauser, Antonella Favit, L Arthur Hewitt, et al.
Pageof 27

Showing results (131-140 of 266) with videos related to

Sort By:
Pageof 27
Parkinson'S Disease|June 17, 2022
Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational SearchGareth Morinan, Robert A Hauser, Anette Schrag, et al.
The Lancet. Neurology|February 15, 2011
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trialRobert A Hauser, Marc Cantillon, Emmanuelle Pourcher, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 28, 2006
Use of nutritional supplements in Parkinson's disease patientsSummer C Wolfrath, Amy R Borenstein, Skai Schwartz, et al.
The International Journal of Neuroscience|December 7, 2016
Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's diseaseElise G Valdés, Melissa L O'Connor, Ergun Y Uc, et al.
Journal of Parkinson'S Disease|March 27, 2023
Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary?Robert A Hauser, William G Ondo, Yi Zhang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2005
Chorea in a patient with cerebral palsy: treatment with levetiracetamMaria V Recio, Robert A Hauser, Elan D Louis, et al.
Frontiers in Neurology|October 26, 2020
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical StudiesAlberto Esquenazi, Mauricio R Delgado, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Substantial improvement in a Meige's syndrome patient with levetiracetam treatmentTheresa A Zesiewicz, Elan D Louis, Kelly L Sullivan, et al.
Clinical Rheumatology|October 17, 2007
Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1Theresa A Zesiewicz, W Reed Shimberg, Robert A Hauser, et al.
Neurology and Therapy|February 2, 2022
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentRobert A Hauser, Antonella Favit, L Arthur Hewitt, et al.
Pageof 27